Comparing The Safety And Efficacy Of Sitagliptin Vs Dapagliflozin And The Risk Of Hyperkalaemia Among People With Type 2 Diabetes Mellitus And Kidney Disease . Vascular and Endovascular Review, [S. l.], v. 8, n. 9s, p. 230–236, 2025. DOI: 10.64149/J.Ver.8.9s.230-236. Disponível em: https://verjournal.com/index.php/ver/article/view/745. Acesso em: 8 apr. 2026.